Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
William D. Travis, Marina K. Baine, Mary Beth Beasley, Elizabeth Brambilla, Lukas Bubendorf, Allen Burke, Andrew Churg, Wendy Cooper, Sanja Dacic, Francoise Galeteau-Salle, Fred R. Hirsch, Keith Kerr, Joseph Maleszewski, Alexander Marx, Andrew G. Nicholson, Masayuki Noguchi, Elizabeth Pavlisko, Natasha Rekhtman, Victor Roggli, Jennifer L. Sauter, Phillipp Stroebel, Ming Sound Tsao, Ignacio Wistuba, Yasushi Yatabe
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
10.1097/jto.0b013e318206a221 · 2011
The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 Classification
10.1097/jto.0000000000000630 · 2015
10.1097/jto.0b013e318290868f
10.1097/jto.0b013e318290868f · 2013
The 2021 WHO classification of lung tumors: impact of advances since 2015
10.1016/j.jtho.2021.11.003 · 2022
PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the Blueprint PD-L1 ihc assay comparison project
10.1016/j.jtho.2016.11.2228 · 2017
Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart
10.1097/jto.0000000000000663 · 2015
PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of Blueprint phase 2 project
10.1016/j.jtho.2018.05.013 · 2018
The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming Eighth Edition of the TNM classification of lung cancer
10.1016/j.jtho.2016.03.025 · 2016
A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee
10.1016/j.jtho.2020.06.001 · 2020
10.1016/j.jtho.2017.12.001
10.1016/j.jtho.2017.12.001 · 2018
IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy
10.1016/j.jtho.2020.01.005 · 2020
The International Association for the Study of Lung Cancer, Lung Cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer
10.1016/j.jtho.2015.10.008 · 2016
Best practices recommendations for diagnostic immunohistochemistry in lung cancer
10.1016/j.jtho.2018.12.005 · 2019
The 2015 World Health Organization classification of tumors of the thymus: continuity and changes
10.1097/jto.0000000000000654 · 2015
The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors?
10.1016/j.jtho.2021.10.010 · 2022
The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification
10.1016/j.jtho.2015.11.005 · 2016
The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification
10.1016/j.jtho.2021.12.014 · 2022
The 2015 WHO classification of tumors of the heart and pericardium
10.1016/j.jtho.2015.11.009 · 2016
The 2021 WHO classification of tumors of the heart
10.1016/j.jtho.2021.10.021 · 2022
Unresolved referenced work
2015
Unresolved referenced work
2021
Small adenocarcinoma of the lung. Histologic characteristics and prognosis
10.1002/1097-0142(19950615)75:12<2844::aid-cncr2820751209>3.0.co;2-# · 1995
Unresolved referenced work
1999
Unresolved referenced work
2004
Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis
10.1097/pas.0b013e31815cb162 · 2008
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage i cases
10.1038/modpathol.2010.232 · 2011
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival
10.1200/jco.2011.37.2185 · 2012
10.1097/jto.0b013e318221f701
10.1097/jto.0b013e318221f701 · 2011
Expansion of the concept of micropapillary adenocarcinoma to include a newly recognized filigree pattern as well as the classical pattern based on 1468 stage I lung adenocarcinomas
10.1016/j.jtho.2019.07.008 · 2019
Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas
10.1097/jto.0000000000000486 · 2015
10.1016/j.jtho.2024.03.015
10.1016/j.jtho.2024.03.015 · 2024
Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification
10.5858/arpa.2012-0264-ra · 2013
Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: comparison with standard histopathologic approach
10.1158/1078-0432.ccr-19-1700 · 2019
Pathologic assessment and staging of multiple non-small cell lung carcinomas: a paradigm shift with the emerging role of molecular methods
10.1016/j.modpat.2024.100453 · 2024
Differentiating separate primary lung adenocarcinomas from intrapulmonary metastases with emphasis on pathological and molecular considerations: recommendations from the international association for the study of lung cancer pathology committee
10.1016/j.jtho.2024.11.016 · 2025
Genomic staging of multifocal lung squamous cell carcinomas is independent of the comprehensive morphologic assessment
10.1016/j.jtho.2023.09.275 · 2024
Defining morphologic features of invasion in pulmonary nonmucinous adenocarcinoma with lepidic growth: a proposal by the International Association for the Study of Lung Cancer Pathology Committee
10.1016/j.jtho.2022.11.026 · 2023
Preinvasive lesions of the bronchus
10.1097/jto.0b013e31819667bd · 2009
Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients
10.1097/jto.0b013e318229189d · 2011
Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes
10.1097/jto.0000000000000253 · 2014
Do “intimal” sarcomas of the heart exist?
10.1097/pas.0000000000000271 · doi-reference
Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature
10.1038/s41379-021-00874-y · doi-reference
Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets
10.1016/j.humpath.2022.02.006 · doi-reference
Cardiac sarcoma with MDM2 amplification
10.1097/pas.0000000000000275 · doi-reference
Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas
10.1097/pas.0000000000000184 · doi-reference
Cardiac angiosarcoma: histopathologic, immunohistochemical, and cytogenetic analysis of 10 cases
10.1016/j.humpath.2016.10.014 · doi-reference
Benign lipomatous masses of the heart: a comprehensive series of 47 cases with cytogenetic evaluation
10.1016/j.humpath.2014.05.003 · doi-reference
KRAS mutations in papillary fibroelastomas: a study of 50 cases with etiologic and diagnostic implications
10.1097/pas.0000000000001448 · doi-reference
Identification of candidate genes for histiocytoid cardiomyopathy (HC) using whole genome expression analysis: analyzing material from the hc registry
10.2350/10-05-0826-oa.1 · doi-reference
Characterization of the clinical, histopathologic, and immunohistochemical features of large papillary fibroelastomas and their S100-expressing spindle cell component and its potential relationship to cardiac valvular interstitial cells
10.1016/j.carpath.2025.107800 · doi-reference
Prognostic and bioepidemiologic implications of papillary fibroelastomas
10.1016/j.jacc.2015.03.569 · doi-reference
PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors
10.1097/pas.0000000000000202 · doi-reference
Cardiac sarcomas: an update
10.1097/jto.0b013e3181e59a91 · doi-reference
A high-grade pleomorphic sarcoma in left atrium
10.1097/jto.0000000000000377 · doi-reference
Neuroendocrine neoplasm update: toward universal nomenclature
10.1530/erc-20-0036 · doi-reference
Characterization, prognosis, and treatment of patients with locally advanced or metastatic thymic neuroendocrine tumor: A retrospective study of the French GTE, ENDOCAN RENATEN, and RYTHMIC networks
10.1016/j.jtho.2025.04.013 · doi-reference
Impact of positive nodal metastases in patients with thymic carcinoma and thymic neuroendocrine tumors
10.1097/jto.0000000000000660 · doi-reference
Molecular classification of neuroendocrine tumors of the thymus
10.1016/j.jtho.2019.04.015 · doi-reference
Paraneoplastic syndromes and thymic malignancies: an examination of the International Thymic Malignancy Interest Group retrospective database
10.1016/j.jtho.2017.11.118 · doi-reference
Cancer immunologists scoop medicine Nobel prize
10.1038/d41586-018-06751-0 · doi-reference
Assessment of the itmig statement on the WHO histological classification and of the Eighth TNM staging of thymic epithelial tumors of a series of 188 thymic epithelial tumors
10.1016/j.jtho.2017.06.072 · doi-reference
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: proposal for the T component for the forthcoming (ninth) edition of the TNM classification of malignant tumors
10.1016/j.jtho.2023.08.024 · doi-reference
10.1016/j.jtho.2023.09.001
10.1016/j.jtho.2023.09.001 · doi-reference
Surgical, radiation, and systemic treatments of patients with thymic epithelial tumors: a clinical practice guideline
10.1016/j.jtho.2022.08.007 · doi-reference
Thymomas and thymic carcinomas, version 2.2025, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2025.0027 · doi-reference
The International Association for the Study of Lung Cancer thymic epithelial tumors staging project: proposal for a stage classification for the forthcoming (ninth) edition of the TNM classification of malignant tumors
10.1016/j.jtho.2023.09.002 · doi-reference
The impact of thymoma histotype on prognosis in a worldwide database
10.1097/jto.0000000000000393 · doi-reference
The International Association for the Study of Lung Cancer thymic epithelial tumors staging project: an overview of the central database informing revision of the forthcoming (ninth) edition of the TNM classification of malignant tumors
10.1016/j.jtho.2023.07.008 · doi-reference
Development of the International Thymic Malignancy Interest Group international database: an unprecedented resource for the study of a rare group of tumors
10.1097/jto.0000000000000269 · doi-reference
A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria
10.1097/jto.0000000000000296 · doi-reference
Thymic carcinomas-a concise multidisciplinary update on recent developments from the thymic carcinoma working group of the International Thymic Malignancy Interest Group
10.1016/j.jtho.2022.01.021 · doi-reference
Expression patterns, prognostic value, and intratumoral heterogeneity of PD-L1 and PD-1 in thymoma and thymic carcinoma
10.1016/j.jtho.2018.04.013 · doi-reference
ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting
10.1097/jto.0000000000000154 · doi-reference
Lymph node dissection in thymic malignancies: implication of the ITMIG lymph node map, TNM stage classification, and recommendations
10.1016/j.jtho.2015.09.001 · doi-reference
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 yields novel insights for the diagnosis of olfactory neuroblastoma and identifies sinonasal tuft cell-like carcinoma
10.1016/j.modpat.2024.100674 · doi-reference
A tuft cell-like signature is highly prevalent in thymic squamous cell carcinoma and delineates new molecular subsets among the major lung cancer histotypes
10.1016/j.jtho.2021.02.008 · doi-reference
Mutations of epigenetic regulatory genes are common in thymic carcinomas
10.1038/srep07336 · doi-reference
Copy number aberrations of BCL2 and CDKN2a/b identified by array-CGH in thymic epithelial tumors
10.1038/cddis.2012.92 · doi-reference
Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis
10.1097/jto.0000000000000397 · doi-reference
The integrated genomic landscape of thymic epithelial tumors
10.1016/j.ccell.2018.01.003 · doi-reference